A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy

Name: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy
License: Public Domain

AbbVie

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

crohn's disease

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 325297
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.